+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Kidney Cancer Drugs Market Research Reports

AVASTIN Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

AVASTIN Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Wilms Tumor Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Thumbnail Image

Wilms Tumor Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • October 2023
  • 182 Pages
  • Global
From
Diabetic Nephropathy (DN) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Diabetic Nephropathy (DN) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • August 2023
  • 76 Pages
  • Global
From
IgA Nephropathy (Berger's Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

IgA Nephropathy (Berger's Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • August 2023
  • 72 Pages
  • Global
From
Avastin (Bevacizumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive/Terminated/Withdrawn Biosimilars, Industry/Non-Industry Partnerships - Product Thumbnail Image

Avastin (Bevacizumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive/Terminated/Withdrawn Biosimilars, Industry/Non-Industry Partnerships

  • Report
  • August 2021
  • 91 Pages
  • Global
From
Kidney Cancer Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (Targeted Therapy, Immunotherapy), By Pharmacologic Class, By Country, And Segment Forecasts, 2016 - 2022 - Product Thumbnail Image

Kidney Cancer Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (Targeted Therapy, Immunotherapy), By Pharmacologic Class, By Country, And Segment Forecasts, 2016 - 2022

  • Report
  • June 2018
  • 99 Pages
  • Global
From
Middle East and Africa Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Middle East and Africa Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 90 Pages
  • Middle East, Africa
From
Europe Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Europe Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 68 Pages
  • Europe
From
Capecitabine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Capecitabine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 121 Pages
  • Global
From
North America Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025) - Product Thumbnail Image

North America Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)

  • Report
  • August 2020
  • 80 Pages
  • North America
From
Asia-Pacific Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025) - Product Thumbnail Image

Asia-Pacific Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)

  • Report
  • June 2020
  • 68 Pages
  • Asia Pacific
From
AFINITOR Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

AFINITOR Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Wilms Tumor - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Wilms Tumor - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Metastatic Renal Cell Carcinoma (mRCC) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Metastatic Renal Cell Carcinoma (mRCC) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Renal cell carcinoma - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Renal cell carcinoma - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Advanced Renal Cell Carcinoma (RCC) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Advanced Renal Cell Carcinoma (RCC) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Renal cell carcinoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Renal cell carcinoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Metastatic Renal Cell Carcinoma (mRCC) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Metastatic Renal Cell Carcinoma (mRCC) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Clear Cell Renal Cell Carcinoma (ccRCC) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Clear Cell Renal Cell Carcinoma (ccRCC) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Wilms Tumor - Epidemiology Forecast to 2032 - Product Thumbnail Image

Wilms Tumor - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Kidney Cancer Drugs market is a subset of the pharmaceutical industry that focuses on the development and sale of drugs used to treat kidney cancer. These drugs are used to reduce the size of tumors, slow the growth of cancer cells, and reduce the spread of cancer to other parts of the body. Common treatments include chemotherapy, targeted therapy, immunotherapy, and surgery. The market is highly competitive, with many companies vying for market share. Major players include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and AstraZeneca. These companies are constantly researching and developing new drugs to improve the treatment of kidney cancer. Additionally, many smaller companies are also involved in the market, offering innovative treatments and therapies. Overall, the Kidney Cancer Drugs market is an important part of the pharmaceutical industry, providing treatments and therapies to improve the lives of those affected by kidney cancer. Show Less Read more